Susan Halabi
Impact in
- Cancer Research top 0.1%
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
- Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
Papers in
-
- Prostate Cancer Treatment and Research 160
- Prostate Cancer Diagnosis and Treatment 66
- Renal cell carcinoma treatment 30
-
- Cancer Genomics and Diagnostics 49
- Cancer, Lipids, and Metabolism 34
- Co-authors
- Eric J. SmallNicholas J. VogelzangPhilip W. KantoffJoel PicusMichael J. MorrisWalter M. StadlerEllen B. KaplanWilliam Kevin Kelly
- Journals
- Journal of Clinical Oncology (134 papers)Cancer (18 papers)Annals of Oncology (14 papers)JCO Precision Oncology (14 papers)Clinical Cancer Research (10 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Susan Halabi
365 papers receiving 16.5k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Cancer Research 4.8k
- Pulmonary and Respiratory Medicine 10.0k
- Oncology 6.6k
- Radiology, Nuclear Medicine and Imaging 2.5k
- Hematology 1.2k
Countries citing papers authored by Susan Halabi
This map shows the geographic impact of Susan Halabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Halabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Halabi more than expected).
Fields of papers citing papers by Susan Halabi
This network shows the impact of papers produced by Susan Halabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Halabi. The network helps show where Susan Halabi may publish in the future.
Co-authors
The 25 scholars most cited alongside Susan Halabi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 12 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 14 | |
| 14 | 2022 | 16 | |
| 15 | 2021 | 19 | |
| 16 | 2021 | 18 | |
| 17 | 2019 | 3 | |
| 18 | Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial Hit paper breakdown → | 2017 | 507 |
| 19 | 2017 | 52 | |
| 20 | 2010 | 62 |
About Susan Halabi
Susan Halabi is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Statistics and Probability and Hematology, having authored 386 papers that have together received 16.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (160 papers), Prostate Cancer Diagnosis and Treatment (66 papers), Cancer Genomics and Diagnostics (49 papers), Radiopharmaceutical Chemistry and Applications (37 papers), Statistical Methods in Clinical Trials (35 papers), Cancer, Lipids, and Metabolism (34 papers), Renal cell carcinoma treatment (30 papers) and Colorectal Cancer Treatments and Studies (26 papers). The work is most often cited by research in Cancer Research (4.8k citations), Pulmonary and Respiratory Medicine (10.0k citations), Oncology (6.6k citations), Radiology, Nuclear Medicine and Imaging (2.5k citations) and Hematology (1.2k citations). Susan Halabi has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Eric J. Small, Nicholas J. Vogelzang, Philip W. Kantoff, Joel Picus, Michael J. Morris, Walter M. Stadler, Ellen B. Kaplan, William Kevin Kelly, Andrew J. Armstrong and Daniel J. George. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, JCO Precision Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.